glp 1 renal impairment Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog The privileged position of glp-1

Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Perics JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V

So, more for my own resource, Im dropping Gabor in here, at least until I find the Peak Human podcast episode where he describes the anatomy of the gut and the biochemistry of gut hormones effects even more clearly: Released from cells in the proximal intestine (closer to stomach) 26252069 585 KB Released from cells in the distal intestine (further from the stomach, closer to the large bowel) 16671618 367 KB This was the podcast where I first listened about Semaglutide/ GLP-1 agonist micro-dosing

For the 12.5 mg and 15 mg doses, you either need a tuberculin syringe or must split the dose across two injections

Transferrin (TF) is a vital iron-binding protein that transports extracellular iron into cells by binding to transferrin receptors on the cell membrane